Gujarat Themis Biosyn Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: GUJTHEM BSE: 506879

₹373.60

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #64 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Gujarat Themis Biosyn Limited (this stock)	4,071	83.6	15.9%	-12.9%	0.18%	78	0	31

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹4,228 Cr

EV / EBITDA

49.9x

EV / Sales

24.33x

Market cap / Sales

23.43x

Earnings yield

1.20%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 44 Cr, up 21.5% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	44	15	11	₹1.0200
March 31, 2026	44	14	11	₹1.0000
Dec. 31, 2025	43	17	12	₹1.1400
Sept. 30, 2025	42	19	14	₹1.3100
June 30, 2025	36	12	9	₹0.8300
March 31, 2025	38	16	12	₹1.1000
Sept. 30, 2024	35	14	11	₹0.9700
June 30, 2024	39	18	13	₹1.8200
March 31, 2024	42	21	16	₹2.1900
Dec. 31, 2023	39	18	13	₹1.7900
Sept. 30, 2023	40	17	13	₹8.6300
June 30, 2023	50	24	18	₹12.2000
March 31, 2023	28	16	12	₹8.0500

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	44	45	44	43	36	39	35	39	43	40	41	51	30
Operating revenue	44	44	43	42	36	38	35	39	42	39	40	50	28
Other income	0	1	0	1	0	1	0	1	1	1	1	1	1
Operating expenses	23	25	22	21	22	22	19	20	21	21	23	26	13
Operating profit	21	19	21	21	14	16	15	19	21	18	17	24	15
Operating profit margin	47.5%	43.8%	49.1%	49.5%	38.8%	42.5%	44.3%	47.8%	49.8%	45.7%	42.4%	47.4%	53.0%
Depreciation	4	4	4	3	2	1	1	1	1	1	1	1	1
Interest	2	2	1	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	15	14	17	19	12	16	14	18	21	18	17	24	16
Tax	4	3	4	4	3	4	4	5	5	5	4	6	4
Net profit	—	—	—	14	9	12	11	13	16	13	13	18	12
EPS	1.02	1.00	1.14	1.31	0.83	1.10	0.97	1.82	2.19	1.79	8.63	12.20	8.05
Net profit (TTM)	—	—	—	46	45	52	53	55	59	55	52	58	58
EPS (TTM)	4.47	4.28	4.38	4.21	4.72	6.08	6.77	14.43	24.81	30.67	35.63	39.87	39.90

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	166	62	47
March 31, 2025	151	66	49

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	2.8%	12.4%	168^†	—	174^†	155^†	119^†	94^†	87^†	43^†	39^†	36^†
Operating revenue	3.6%	12.9%	166	151	170^†	149^†	115^†	91^†	85^†	41^†	39^†	36^†
Other income	—	—	2^†	—	4^†	6^†	4^†	3^†	2^†	2^†	0^†	0^†
Operating expenses	—	—	90^†	—	91^†	75^†	57^†	50^†	53^†	34^†	33^†	—
Operating profit	0.6%	13.4%	76^†	—	79^†	74^†	58^†	40^†	32^†	7^†	6^†	—
Operating profit margin	—	—	45.6%^†	—	46.4%^†	49.8%^†	50.5%^†	44.5%^†	37.4%^†	17.9%^†	15.9%^†	—
Depreciation	—	—	13^†	—	4^†	3^†	2^†	2^†	1^†	1^†	1^†	1^†
Interest	—	—	3^†	—	0^†	0^†	1^†	1^†	1^†	0^†	0^†	—
Exceptional items, gain / (loss)	—	—	0^†	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	-7.1%	8.7%	62	66	79^†	77^†	59^†	41^†	31^†	8^†	5^†	5^†
Tax	—	—	15^†	—	20^†	19^†	15^†	11^†	8^†	2^†	1^†	—
Net profit	-7.0%	9.1%	47	49	59^†	58^†	44^†	30^†	24^†	6^†	4^†	4^†
EPS	-52.5%	-27.1%	4.28^†	—	24.81^†	39.90^†	30.02^†	20.78^†	16.29^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	45.6%^†	—	46.4%^†	49.8%^†	50.5%^†	44.5%^†	37.4%^†	17.9%^†	15.9%^†	—
EBIT margin	39.2%^†	—	46.8%^†	52.1%^†	52.1%^†	46.2%^†	37.8%^†	20.3%^†	13.4%^†	—
PBT margin	37.4%	43.5%	46.6%^†	52.0%^†	51.4%^†	45.1%^†	36.7%^†	20.0%^†	12.3%^†	13.2%^†
Net margin	28.2%	32.3%	34.8%^†	38.9%^†	38.0%^†	33.3%^†	27.8%^†	15.6%^†	9.8%^†	11.9%^†
Interest coverage	22.06x^†	—	347.29x^†	386.97x^†	72.31x^†	42.66x^†	34.85x^†	61.62x^†	12.43x^†	—
Dividend payout	15.7%^†	—	0.0%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	—	—	—
Earnings retention	84.3%^†	—	100.0%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	—	—	—
Current ratio	1.12x	2.53x	—	—	—	—	—	—	—	—
Quick ratio	0.93x	2.28x	—	—	—	—	—	—	—	—
Debt to equity	0.56x	0.12x	—	—	—	—	—	—	—	—
Return on equity	16.2%	19.6%	—	—	—	—	—	—	—	—
Return on assets	9.3%	16.2%	—	—	—	—	—	—	—	—
Return on capital employed	15.3%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.33x	0.50x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	49	-172	115	173	-124
March 31, 2025	91	-112	26	116	-25

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	503	288	277	32	128	89	79	3	287	15
March 31, 2025	301	248	237	0	30	52	21	12	41	5

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.